FEMASYS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.3M | $1.6M | $1.1M | $1.2M | $1.2M |
| Cost of revenue | $872,400 | $544,903 | $380,069 | $441,938 | $370,384 |
| Gross profit | — | — | — | $764,280 | $809,305 |
| Research and development | $7.6M | $8.2M | $7.2M | $5.8M | $4.1M |
| Operating expenses | $19.0M | $18.9M | $15.2M | $12.4M | $9.1M |
| Operating income | -$17.6M | -$17.8M | -$14.5M | -$11.6M | -$8.3M |
| Interest expense | $1.9M | $1.6M | $165,390 | $13,464 | $19,226 |
| Pretax income | -$18.6M | -$18.8M | -$14.2M | -$11.4M | -$7.5M |
| Income tax expense | $1,297 | $9,602 | $4,338 | $6,300 | $4,000 |
| Net income | -$18.6M | -$18.8M | -$14.2M | -$11.4M | -$7.5M |
| Balance Sheet | |||||
| Cash and equivalents | $9.3M | $3.5M | $21.7M | $13.0M | $24.8M |
| Current assets | $16.5M | $8.0M | $23.2M | $14.1M | $25.6M |
| Total assets | $20.7M | $12.4M | $27.8M | $16.9M | $28.6M |
| Current liabilities | $3.6M | $8.6M | $3.1M | $1.5M | $1.7M |
| Total liabilities | $14.9M | $10.1M | $9.4M | $1.7M | $2.2M |
| Stockholders' equity | $5.9M | $2.3M | $18.4M | $15.2M | $26.3M |
| Cash Flow Statement | |||||
| Cash from operations | -$18.7M | -$19.4M | -$11.3M | -$10.7M | -$7.9M |
| Depreciation and amortization | $295,859 | $277,178 | $480,187 | $539,434 | $551,092 |
| Stock-based compensation | $790,145 | $444,147 | $675,700 | $224,939 | $193,366 |
| Capital expenditure | $525,007 | $761,706 | $143,917 | $407,475 | $306,868 |
| Free cash flow | -$19.2M | -$20.2M | -$11.4M | -$11.1M | -$8.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | — | $60,753 | $229,953 | $0 | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 60.4M · Free float 91.9%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.